nach oben

Journal of Neurology

Erschienen in:

01.08.2013 | Review

Psychiatric comorbidities of episodic and chronic migraine

verfasst von: Dawn C. Buse, Stephen D. Silberstein, Aubrey N. Manack, Spyros Papapetropoulos, Richard B. Lipton

Erschienen in: Journal of Neurology | Ausgabe 8/2013

Einloggen, um Zugang zu erhalten

Abstract

Migraine is a prevalent disabling neurological disorder associated with a wide range of medical and psychiatric comorbidities. Population- and clinic-based studies suggest that psychiatric comorbidities, particularly mood and anxiety disorders, are more common among persons with chronic migraine than among those with episodic migraine. Additional studies suggest that psychiatric comorbidities may be a risk factor for migraine chronification (i.e., progression from episodic to chronic migraine). It is important to identify and appropriately treat comorbid psychiatric conditions in persons with migraine, as these conditions may contribute to increased migraine-related disability and impact, diminished health-related quality of life, and poor treatment outcomes. Here, we review the current literature on the rates of several psychiatric comorbidities, including depression, anxiety, and post-traumatic stress disorder, among persons with migraine in clinic- and population-based studies. We also review the link between physical, emotional, and substance abuse, psychiatric disorders, and migraine. Finally, we review the data on psychiatric risk factors for migraine chronification and explore theories and evidence underlying the comorbidity between migraine and these psychiatric disorders.

Nur mit Berechtigung zugänglich

Lipton RB, Silberstein SD (1994) Why study the comorbidity of migraine? Neurology 44:S4–S5PubMedCrossRef

Merikangas KR, Stevens DE (1997) Comorbidity of migraine and psychiatric disorders. Neurol Clin 15:115–123PubMedCrossRef

Breslau N, Davis GC, Andreski P (1991) Migraine, psychiatric disorders, and suicide attempts: an epidemiologic study of young adults. Psychiatry Res 37:11–23PubMedCrossRef

Merikangas KR, Angst J, Isler H (1990) Migraine and psychopathology. Results of the Zurich cohort study of young adults. Arch Gen Psychiatry 47:849–853PubMedCrossRef

Hamelsky SW, Lipton RB (2006) Psychiatric comorbidity of migraine. Headache 46:1327–1333PubMedCrossRef

Tietjen GE, Brandes JL, Peterlin BL, Eloff A, Dafer RM, Stein MR, Drexler E, Martin VT, Hutchinson S, Aurora SK, Recober A, Herial NA, Utley C, White L, Khuder SA (2010) Childhood maltreatment and migraine (part I). Prevalence and adult revictimization: a multicenter headache clinic survey. Headache 50:20–31PubMedCrossRef

Peterlin BL, Rosso AL, Sheftell FD, Libon DJ, Mossey JM, Merikangas KR (2011) Post-traumatic stress disorder, drug abuse and migraine: new findings from the National Comorbidity Survey Replication (NCS-R). Cephalalgia 31:235–244PubMedCrossRef

Jette N, Patten S, Williams J, Becker W, Wiebe S (2008) Comorbidity of migraine and psychiatric disorders—a national population-based study. Headache 48:501–516PubMedCrossRef

Silberstein SD, Dodick D, Freitag F, Pearlman SH, Hahn SR, Scher AI, Lipton RB (2007) Pharmacological approaches to managing migraine and associated comorbidities—clinical considerations for monotherapy versus polytherapy. Headache 47:585–599PubMedCrossRef

10.

Ashina S, Serrano D, Lipton RB, Maizels M, Manack AN, Turkel CC, Reed ML, Buse DC (2012) Depression and risk of transformation of episodic to chronic migraine: results of the American Migraine Prevalence and Prevention study. Enrico Greppi Award 2012. J Headache Pain 13:615–624

11.

Breslau N, Schultz L, Lipton R, Peterson E, Welch KM (2012) Migraine headaches and suicide attempt. Headache 52:723–731PubMedCrossRef

12.

(2004) The international classification of headache disorders: 2nd edition. Cephalalgia 24 Suppl 1:9–160

13.

Manack A, Turkel C, Silberstein S (2009) The evolution of chronic migraine: classification and nomenclature. Headache 49:1206–1213PubMedCrossRef

14.

Olesen J, Bousser MG, Diener HC, Dodick D, First M, Goadsby PJ, Gobel H, Lainez MJ, Lance JW, Lipton RB, Nappi G, Sakai F, Schoenen J, Silberstein SD, Steiner TJ (2006) New appendix criteria open for a broader concept of chronic migraine. Cephalalgia 26:742–746PubMedCrossRef

15.

Bigal ME, Tepper SJ, Sheftell FD, Rapoport AM, Lipton RB (2006) Field testing alternative criteria for chronic migraine. Cephalalgia 26:477–482PubMedCrossRef

16.

Lipton RB (2011) Chronic migraine, classification, differential diagnosis, and epidemiology. Headache 51(Suppl 2):77–83PubMedCrossRef

17.

Silberstein SD, Lipton RB, Sliwinski M (1996) Classification of daily and near-daily headaches: field trial of revised IHS criteria. Neurology 47:871–875PubMedCrossRef

18.

Couch J, Taylor K, Hilliard B (2003) Migraine in the primary care population: prevalence, severity and disability. Headache 43:570–571 [abstract S128]

19.

Blumenfeld A, Varon S, Wilcox TK, Buse D, Kawata AK, Manack A, Goadsby PJ, Lipton RB (2011) Disability, HRQoL and resource use among chronic and episodic migraineurs: results from the International Burden of Migraine Study (IBMS). Cephalalgia 31:301–315PubMedCrossRef

20.

Buse DC, Manack A, Serrano D, Turkel C, Lipton RB (2010) Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers. J Neurol Neurosurg Psychiatry 81:428–432PubMedCrossRef

21.

Buse DC, Rupnow MF, Lipton RB (2009) Assessing and managing all aspects of migraine: migraine attacks, migraine-related functional impairment, common comorbidities, and quality of life. Mayo Clin Proc 84:422–435PubMed

22.

Breslau N, Schultz LR, Stewart WF, Lipton RB, Lucia VC, Welch KM (2000) Headache and major depression: is the association specific to migraine? Neurology 54:308–313PubMedCrossRef

23.

Lipton RB, Hamelsky SW, Kolodner KB, Steiner TJ, Stewart WF (2000) Migraine, quality of life, and depression: a population-based case–control study. Neurology 55:629–635PubMedCrossRef

24.

Zwart JA, Dyb G, Hagen K, Ødegård KJ, Dahl AA, Bovim G, Stovner LJ (2003) Depression and anxiety disorders associated with headache frequency. The Nord-Trondelag Health Study. Eur J Neurol 10:147–152PubMedCrossRef

25.

Kroenke K, Spitzer RL, Williams JB (2001) The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 16:606–613PubMedCrossRef

26.

Kroenke K, Spitzer RL (2002) The PHQ-9: a new depression diagnostic and severity measure. Psych Ann 32:1–7

27.

Kroenke K, Spitzer RL, Williams JB, Lowe B (2010) The patient health questionnaire somatic, anxiety, and depressive symptom scales: a systematic review. Gen Hosp Psychiatry 32:345–359PubMedCrossRef

28.

Kroenke K, Spitzer RL, Williams JB, Löwe B (2009) An ultra-brief screening scale for anxiety and depression: the PHQ-4. Psychosomatics 50:613–621PubMed

29.

Chen YC, Tang CH, Ng K, Wang SJ (2012) Comorbidity profiles of chronic migraine sufferers in a national database in Taiwan. J Headache Pain 13:311–319PubMedCrossRef

30.

Bigal ME, Serrano D, Buse D, Scher A, Stewart WF, Lipton RB (2008) Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population-based study. Headache 48:1157–1168PubMedCrossRef

31.

Bigal M (2009) Migraine chronification—concept and risk factors. Discov Med 8:145–150PubMed

32.

Manack A, Buse DC, Serrano D, Turkel CC, Lipton RB (2011) Rates, predictors, and consequences of remission from chronic migraine to episodic migraine. Neurology 76:711–718PubMedCrossRef

33.

Boudreau GP, Grosberg BM, McAllister PJ, Sheftell FD, Lipton RB, Buse DC (2010) Open-label, multicenter study of the efficacy and outcome of onabotulinumtoxin—a treatment in patients with chronic migraine and comorbid depressive disorders. p 241

34.

Beck AT, Steer RA, Ball R, Ranieri W (1996) Comparison of Beck depression inventories -IA and -II in psychiatric outpatients. J Pers Assess 67:588–597PubMedCrossRef

35.

Ashina S, Buse DC, Maizels M, Manack A, Serrrano D, Turkel CC, Lipton RB (2010) Self-reported anxiety as a risk factor for migraine chronification: results from the American Migraine Prevalence and Prevention (AMPP) study. Headache 50 Suppl 1:4 [PO-8]

36.

Guidetti V, Galli F, Fabrizi P, Giannantoni AS, Napoli L, Bruni O, Trillo S (1998) Headache and psychiatric comorbidity: clinical aspects and outcome in an 8-year follow-up study. Cephalalgia 18:455–462PubMedCrossRef

37.

Peterlin BL, Tietjen GE, Brandes JL, Rubin SM, Drexler E, Lidicker JR, Meng S (2009) Posttraumatic stress disorder in migraine. Headache 49:541–551PubMedCrossRef

38.

Kessler RC (2000) Posttraumatic stress disorder: the burden to the individual and to society. J Clin Psychiatry 61(Suppl 5):4–12PubMed

39.

Peterlin BL, Tietjen G, Meng S, Lidicker J, Bigal M (2008) Post-traumatic stress disorder in episodic and chronic migraine. Headache 48:517–522PubMedCrossRef

40.

Breslau N, Kessler RC, Chilcoat HD, Schultz LR, Davis GC, Andreski P (1998) Trauma and posttraumatic stress disorder in the community: the 1996 Detroit area survey of trauma. Arch Gen Psychiatry 55:626–632PubMedCrossRef

41.

Peterlin BL, Ward T, Lidicker J, Levin M (2007) A retrospective, comparative study on the frequency of abuse in migraine and chronic daily headache. Headache 47:397–401PubMed

42.

Tietjen GE, Brandes JL, Peterlin BL, Eloff A, Dafer RM, Stein MR, Drexler E, Martin VT, Hutchinson S, Aurora SK, Recober A, Herial NA, Utley C, White L, Khuder SA (2010) Childhood maltreatment and migraine (part II). Emotional abuse as a risk factor for headache chronification. Headache 50:32–41PubMedCrossRef

43.

McCauley J, Kern DE, Kolodner K, Dill L, Schroeder AF, DeChant HK, Ryden J, Derogatis LR, Bass EB (1997) Clinical characteristics of women with a history of childhood abuse: unhealed wounds. JAMA 277:1362–1368PubMedCrossRef

44.

Widom CS, DuMont K, Czaja SJ (2007) A prospective investigation of major depressive disorder and comorbidity in abused and neglected children grown up. Arch Gen Psychiatry 64:49–56PubMedCrossRef

45.

Vranceanu AM, Hobfoll SE, Johnson RJ (2007) Child multi-type maltreatment and associated depression and PTSD symptoms: the role of social support and stress. Child Abuse Negl 31:71–84PubMedCrossRef

46.

Breslau N, Davis GC, Schultz LR, Peterson EL (1994) Joint 1994 Wolff Award Presentation. Migraine and major depression: a longitudinal study. Headache 34:387–393PubMedCrossRef

47.

Breslau N, Lipton RB, Stewart WF, Schultz LR, Welch KM (2003) Comorbidity of migraine and depression: investigating potential etiology and prognosis. Neurology 60:1308–1312PubMedCrossRef

48.

Breslau N, Schultz LR, Stewart WF, Lipton R, Welch KM (2001) Headache types and panic disorder: directionality and specificity. Neurology 56:350–354PubMedCrossRef

49.

Merikangas KR, Risch NJ, Merikangas JR, Weissman MM, Kidd KK (1988) Migraine and depression: association and familial transmission. J Psychiatr Res 22:119–129PubMedCrossRef

50.

Merikangas KR, Merikangas JR, Angst J (1993) Headache syndromes and psychiatric disorders: association and familial transmission. J Psychiatr Res 27:197–210PubMedCrossRef

51.

Burstein R, Jakubowski M (2009) Neural substrate of depression during migraine. Neurol Sci 30(Suppl 1):S27–S31PubMedCrossRef

52.

Barbanti P, Fabbrini G, Ricci A, Pascali MP, Bronzetti E, Amenta F, Lenzi GL, Cerbo R (2000) Migraine patients show an increased density of dopamine D3 and D4 receptors on lymphocytes. Cephalalgia 20:15–19PubMedCrossRef

53.

Ferrari MD, Saxena PR (1993) On serotonin and migraine: a clinical and pharmacological review. Cephalalgia 13:151–165PubMedCrossRef

54.

Hamel E (2007) Serotonin and migraine: biology and clinical implications. Cephalalgia 27:1293–1300PubMedCrossRef

55.

Smitherman TA, Penzien DB, Maizels M (2008) Anxiety disorders and migraine intractability and progression. Curr Pain Headache Rep 12:224–229PubMedCrossRef

56.

Finocchi C, Villani V, Casucci G (2010) Therapeutic strategies in migraine patients with mood and anxiety disorders: clinical evidence. Neurol Sci 31(Suppl 1):S95–S98PubMedCrossRef

57.

Bigal ME, Ashina S, Burstein R, Reed ML, Buse D, Serrano D, Lipton RB (2008) Prevalence and characteristics of allodynia in headache sufferers: a population study. Neurology 70:1525–1533PubMedCrossRef

58.

Spitzer RL, Kroenke K, Williams JB (1999) Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. primary care evaluation of mental disorders. Patient health questionnaire. JAMA 282:1737–1744PubMedCrossRef

59.

Gray MJ, Litz BT, Hsu JL, Lombardo TW (2004) Psychometric properties of the life events checklist. Assessment 11:330–341PubMedCrossRef

60.

Snaith RP (2003) The hospital anxiety and depression scale. Health Qual Life Outcomes 1:29PubMedCrossRef

61.

Wilkins KC, Lang AJ, Norman SB (2011) Synthesis of the psychometric properties of the PTSD checklist (PCL) military, civilian, and specific versions. Depress Anxiety 28:596–606PubMedCrossRef

62.

Ratcliffe GE, Enns MW, Jacobi F, Belik SL, Sareen J (2009) The relationship between migraine and mental disorders in a population-based sample. Gen Hosp Psychiatry 31:14–19PubMedCrossRef

Titel: Psychiatric comorbidities of episodic and chronic migraine
verfasst von: Dawn C. Buse
Stephen D. Silberstein
Aubrey N. Manack
Spyros Papapetropoulos
Richard B. Lipton
Publikationsdatum: 01.08.2013
Verlag: Springer Berlin Heidelberg
Erschienen in: Journal of Neurology / Ausgabe 8/2013
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI: https://doi.org/10.1007/s00415-012-6725-x

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

23.04.2024 | Demenz | Nachrichten

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Psychiatric comorbidities of episodic and chronic migraine

Abstract

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Demenzkranke durch Antipsychotika vielfach gefährdet

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Hustenstiller lindert Agitation bei Alzheimer

Update Neurologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 8/2013

Initial cognitive dip after subthalamic deep brain stimulation in Parkinson disease

Laminar infarcts in clinical routine: a prospective analysis in standard stroke unit patients

FAB-D: German version of the Frontal Assessment Battery

Antiplatelet therapy, but not intravenous thrombolytic therapy, is associated with postoperative bleeding complications after decompressive craniectomy for stroke

Lessons from preclinical disease

Investigating the role of the corpus callosum in regulating motor overflow in multiple sclerosis

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Demenzkranke durch Antipsychotika vielfach gefährdet

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Hustenstiller lindert Agitation bei Alzheimer

Update Neurologie